companydata.dkBUSINESS ANGELS FOND - LONDON III A/S: Financial statements 2023
CVR: 36450754
BUSINESS ANGELS FOND - LONDON III A/S (CVR 36450754) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -17,731 and a net result of DKK -276,503 compared with DKK -15,385 the year before. Equity amounted to DKK 1,353,924. The solvency ratio was 98.9%.
- Gross Profit
- -17,731 kr.
- Profit/Loss
- -276,503 kr.
- Equity
- 1,353,924 kr.
- Total Assets
- 1,369,549 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -18 t. | -277 t. | 1.4 mio. | 0 |
| 2022 | - | -19 t. | -15 t. | 1.6 mio. | 0 |
| 2021 | - | -20 t. | -17 t. | 1.6 mio. | 0 |
| 2020 | - | -16 t. | -242 t. | 1.6 mio. | 0 |
| 2019 | - | -16 t. | -1.4 mio. | 1.9 mio. | 0 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BUSINESS ANGELS FOND - LONDON III A/S has published its annual report for 2022. Gross profit came to DKK -18,798, and the net result was DKK -15,385.
About BUSINESS ANGELS FOND - LONDON III A/S
BUSINESS ANGELS FOND - LONDON III A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 2014. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jesper Jarlbæk. The company's owners include Jens Christian Hesse Rasmussen, Jesper Højberg Christensen and CARDIOPHARMA ApS. In 2025, the company reported a gross profit of DKK -12,501 and a net result of DKK -748,113 compared with DKK -23,758 the year before. Equity amounted to DKK 641,789.